Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Somatostatin Receptor Type 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Somatostatin Receptor Type 2market, defines the market attractiveness level of Somatostatin Receptor Type 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Somatostatin Receptor Type 2 industry, describes the types of Somatostatin Receptor Type 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Somatostatin Receptor Type 2 market and the development prospects and opportunities of Somatostatin Receptor Type 2 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Somatostatin Receptor Type 2 market in Chapter 13.
By Player:
Zucara Therapeutics Inc
Ipsen SA
Amryt Pharma plc
Strongbridge Biopharma plc
Daewoong Pharmaceutical Co Ltd
Progenics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
By Type:
CRN-00808
Lanreotide Acetate
PRL-2903
Others
By End-User:
Hormonal Disorder
Oncology
Metabolic Disorder
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Somatostatin Receptor Type 2 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Somatostatin Receptor Type 2 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Somatostatin Receptor Type 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Somatostatin Receptor Type 2 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Somatostatin Receptor Type 2 Market Analysis and Outlook to 2022
-
7.1 Global Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.2 United States Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.3 Europe Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.4 China Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.5 Japan Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.6 India Somatostatin Receptor Type 2 Consumption (2017-2022)
-
7.7 South Korea Somatostatin Receptor Type 2 Consumption (2017-2022)
8 Region and Country-wise Somatostatin Receptor Type 2 Market Analysis and Outlook to 2028
-
8.1 Global Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.2 United States Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.3 Europe Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.4 China Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.5 Japan Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.6 India Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
-
8.7 South Korea Somatostatin Receptor Type 2 Consumption Forecast (2022-2028)
9 Global Somatostatin Receptor Type 2 Market Outlook by Types and Applications to 2022
-
9.1 Global Somatostatin Receptor Type 2 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CRN-00808 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lanreotide Acetate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global PRL-2903 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Somatostatin Receptor Type 2 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hormonal Disorder Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Metabolic Disorder Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Somatostatin Receptor Type 2 Market Outlook by Types and Applications to 2028
-
10.1 Global Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CRN-00808 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lanreotide Acetate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global PRL-2903 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hormonal Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Somatostatin Receptor Type 2 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Somatostatin Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Somatostatin Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Somatostatin Receptor Type 2 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Somatostatin Receptor Type 2 Market Competitive Analysis
-
14.1 Zucara Therapeutics Inc
-
14.1.1 Zucara Therapeutics Inc Company Details
-
14.1.2 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product and Service
-
14.2 Ipsen SA
-
14.2.1 Ipsen SA Company Details
-
14.2.2 Ipsen SA Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ipsen SA Somatostatin Receptor Type 2 Product and Service
-
14.3 Amryt Pharma plc
-
14.3.1 Amryt Pharma plc Company Details
-
14.3.2 Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amryt Pharma plc Somatostatin Receptor Type 2 Product and Service
-
14.4 Strongbridge Biopharma plc
-
14.4.1 Strongbridge Biopharma plc Company Details
-
14.4.2 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product and Service
-
14.5 Daewoong Pharmaceutical Co Ltd
-
14.5.1 Daewoong Pharmaceutical Co Ltd Company Details
-
14.5.2 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product and Service
-
14.6 Progenics Pharmaceuticals Inc
-
14.6.1 Progenics Pharmaceuticals Inc Company Details
-
14.6.2 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Service
-
14.7 Crinetics Pharmaceuticals Inc
-
14.7.1 Crinetics Pharmaceuticals Inc Company Details
-
14.7.2 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Somatostatin Receptor Type 2
-
Figure Somatostatin Receptor Type 2 Picture
-
Table Global Somatostatin Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Receptor Type 2 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Somatostatin Receptor Type 2 Consumption by Country (2017-2022)
-
Figure United States Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Table Europe Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure China Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Japan Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure India Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Somatostatin Receptor Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Somatostatin Receptor Type 2 Consumption Forecast by Country (2022-2028)
-
Figure United States Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Somatostatin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CRN-00808 Consumption and Growth Rate (2017-2022)
-
Figure Global Lanreotide Acetate Consumption and Growth Rate (2017-2022)
-
Figure Global PRL-2903 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CRN-00808 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lanreotide Acetate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PRL-2903 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Somatostatin Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Somatostatin Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)
-
Table Zucara Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product and Service
-
Table Ipsen SA (Foundation Year, Company Profile and etc.)
-
Table Ipsen SA Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen SA Somatostatin Receptor Type 2 Product and Service
-
Table Amryt Pharma plc (Foundation Year, Company Profile and etc.)
-
Table Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amryt Pharma plc Somatostatin Receptor Type 2 Product and Service
-
Table Strongbridge Biopharma plc (Foundation Year, Company Profile and etc.)
-
Table Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product and Service
-
Table Daewoong Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product and Service
-
Table Progenics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Service
-
Table Crinetics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Service
-
